Anti-Bcl-XL antibody [HL2039],Abcam,AB317127

Host

Rabbit

Reactivity

Human, Cat, Dog

Application

ICC/IF, WB, IHC-P

Platform ID

BAB597724892

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Bcl-XL antibody [HL2039]
Cat. No.AB317127
HostRabbit
IsotypeIgG
ReactivityHuman, Cat, Dog
ApplicationICC/IF, WB, IHC-P
ClonalityMonoclonal
Clone NumberHL2039
Concentration1 mg/mL Batch dependent concentration
ImmunogenRecombinant Fragment Protein within Human BCL2L1.
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.. Isoform Bcl-X(L) also regulates presynaptic plasticity, including neurotransmitter release and recovery, number of axonal mitochondria as well as size and number of synaptic vesicle clusters. During synaptic stimulation, increases ATP availability from mitochondria through regulation of mitochondrial membrane ATP synthase F(1)F(0) activity and regulates endocytic vesicle retrieval in hippocampal neurons through association with DMN1L and stimulation of its GTPase activity in synaptic vesicles. May attenuate inflammation impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed : 17418785).. Isoform Bcl-X(S) promotes apoptosis. See full target information BCL2L1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.